ArticleBMC medical imaging2026
Diagnostic performance of conventional ultrasound and shear wave elastography of the parotid glands in primary Sjögren's syndrome.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo evaluate the diagnostic performance of the OMERACT scoring system and shear wave elastography (SWE) of the parotid glands (PG) for primary Sjögren’s syndrome (pSS).
methodsA total of 190 subjects were enrolled, comprising 79 patients diagnosed with pSS according to the 2016 ACR/EULAR classification criteria and 111 non-pSS individuals. After obtaining OMERACT scores (0–3) and SWE values using parotid gland ultrasonography, we defined an adjusted OMERACT score as the original score plus 1 point (not exceeding 3) when the PG SWE mean value exceeded the optimal cut-off of 12.3 kPa. The diagnostic performance of the OMERACT score, SWE mean, and the adjusted OMERACT score was then assessed.
resultsReceiver operating characteristic (ROC) curve analysis revealed that the area under the curve (AUC) for the OMERACT score in predicting pSS was 0.825, while the AUC for PG SWE mean was 0.852, with optimal cut-off values of 1 and 12.3 kPa, respectively. The corresponding sensitivities were 79.7% and 89.9%, and the specificities were 74.8% and 78.4%. Using this adjustment, the adjusted OMERACT score achieved an AUC of 0.912, with an optimal cut-off of 2, a sensitivity of 75.9%, and a specificity of 91.9%. The adjusted OMERACT score effectively distinguished the pSS group from the non-pSS group.
conclusionsThe OMERACT scoring system and SWE demonstrate considerable clinical value in diagnosing pSS. They provide a practical and effective non-invasive approach that can be integrated into the diagnostic workflow, offering a more convenient and efficient examination for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.